| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.003 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |